Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory

Am J Hematol. 2019 Jan;94(1):E24-E27. doi: 10.1002/ajh.25328. Epub 2018 Nov 25.

Authors

Loïc Renaud^{1

2}, Olivier Nibourel^{2

3}, Alice Marceau-Renaut^{2

3}, Bérengère Gruson⁴, Nathalie Cambier^{5

6}, Pauline Lionne-Huyghe⁷, Bachra Choufi⁸, Céline Rodriguez³, Cécile Frimat³, Isabelle Plantier⁹, Laure Stalnikiewicz¹⁰, Maxime Bemba¹¹, Céline Berthon^{1

2}, Jean-Pierre Marolleau⁴, Bruno Quesnel^{1

2}, Claude Preudhomme^{2

3}, Nicolas Duployez^{2

3}

Affiliations

¹ Department of Hematology, CHU Lille, Lille, France.
² Inserm, UMR-S 1172, Lille, France.
³ Laboratory of Hematology, CHU Lille, Lille, France.
⁴ Department of Hematology, CHU Amiens, Amiens, France.
⁵ Department of Hematology, Hôpital St Vincent, Lille, France.
⁶ Department of Hematology, CH Valenciennes, Valenciennes, France.
⁷ Department of Hematology, CH Arras, Arras, France.
⁸ Department of Hematology, CH Boulogne-sur-mer, Boulogne-sur-mer, France.
⁹ Department of Hematology, CH Roubaix, Roubaix, France.
¹⁰ Department of Hematology, CH Lens, Lens, France.
¹¹ Department of Hematology, CH Dunkerque, Dunkerque, France.

PMID: 30358899
DOI: 10.1002/ajh.25328

No abstract available

Publication types

Letter

MeSH terms

Aged, 80 and over
Chromosome Aberrations
Female
France / epidemiology
Genes, Neoplasm
Genetic Heterogeneity
Humans
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / epidemiology
Leukemia, Myeloid, Acute / genetics*
Male
Molecular Targeted Therapy
Mutation
Neoplasms, Second Primary / drug therapy
Neoplasms, Second Primary / epidemiology
Neoplasms, Second Primary / genetics
Prognosis